Egan, K. S., Lyman, G. H., Kreizenbeck, K. L., McCune, J. S., Crawford, J. A., Kusnir-Wong, T. L., … Ramsey, S. D. (2016). Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens. In Value in Health (Vol. 19, pp. A760–A760). Elsevier BV. https://doi.org/10.1016/j.jval.2016.09.2360

Egan, K. S., G. H. Lyman, K. L. Kreizenbeck, J. S. McCune, J. A. Crawford, T. L. Kusnir-Wong, F. M. Stewart, B. E. Greer, and S. D. Ramsey. “Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens.” In Value in Health, 19:A760–A760. Elsevier BV, 2016. https://doi.org/10.1016/j.jval.2016.09.2360.

Egan KS, Lyman GH, Kreizenbeck KL, McCune JS, Crawford JA, Kusnir-Wong TL, et al. Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens. In: Value in Health. Elsevier BV; 2016. p. A760–A760.

Egan, K. S., et al. “Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens.” Value in Health, vol. 19, no. 7, Elsevier BV, 2016, pp. A760–A760. Crossref, doi:10.1016/j.jval.2016.09.2360.

Egan KS, Lyman GH, Kreizenbeck KL, McCune JS, Crawford JA, Kusnir-Wong TL, Stewart FM, Greer BE, Ramsey SD. Compiling and Reconciling Evidence to Assign Risk of Febrile Neutropenia to Chemotherapy Regimens. Value in Health. Elsevier BV; 2016. p. A760–A760.